Glenmede Trust’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-15,774
| Closed | -$291K | – | 1359 |
|
|
2022
Q4 | $291K | Buy |
15,774
+4,641
| +42% | +$85.7K | ﹤0.01% | 994 |
|
|
2022
Q3 | $300K | Buy |
+11,133
| New | +$300K | ﹤0.01% | 961 |
|
|
2020
Q4 | – | Sell |
-1,961
| Closed | -$49K | – | 2320 |
|
|
2020
Q3 | $49K | Buy |
1,961
+61
| +3% | +$1.52K | ﹤0.01% | 1340 |
|
|
2020
Q2 | $46K | Sell |
1,900
-1,482
| -44% | -$35.9K | ﹤0.01% | 1338 |
|
|
2020
Q1 | $54K | Hold |
3,382
| – | – | ﹤0.01% | 1659 |
|
|
2019
Q4 | $54K | Sell |
3,382
-68
| -2% | -$1.09K | ﹤0.01% | 1659 |
|
|
2019
Q3 | $44 | Hold |
3,450
| – | – | ﹤0.01% | 1720 |
|
|
2019
Q2 | $44 | Buy |
3,450
+3,340
| +3,036% | +$43 | ﹤0.01% | 1740 |
|
|
2019
Q1 | $1 | Hold |
110
| – | – | ﹤0.01% | 2977 |
|
|
2018
Q4 | $2 | Buy |
+110
| New | +$2 | ﹤0.01% | 2803 |
|